Estrapronicate (INN ), also known as estradiol nicotinate propionate is an estrogen medication and estrogen ester which was never marketed.[1] It was studied as a component of the experimental tristeroid combination drug Trophobolene, which contained nandrolone decanoate, estrapronicate, and hydroxyprogesterone heptanoate.[2][3]
Clinical data | |
---|---|
Other names | Estradiol propionicotinate; Estradiol propionate nicotinate; Estradiol nicotinate propionate; Estradiol 17β-nicotinate 3-propionate |
Routes of administration | Intramuscular injection |
Drug class | Estrogen; Estrogen ester |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.021.786 |
Chemical and physical data | |
Formula | C27H31NO4 |
Molar mass | 433.548 g·mol−1 |
3D model (JSmol) | |
| |
|
See also
editReferences
edit- ^ Elks J (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. pp. 898–. ISBN 978-1-4757-2085-3.
- ^ Excerpta medica. Section 8, Neurology and neurosurgery. 1981. p. 10.
- ^ Testosterone Congeners—Advances in Research and Application: 2013 Edition: ScholarlyBrief. ScholarlyEditions. 21 June 2013. pp. 137–. ISBN 978-1-4816-9288-5.